GVI Oncology

Port Elizabeth 6045

0 studies enrolling now · 3 studies all time

What they study most

Castration-Resistant Prostate Cancer, Kidney Neoplasms, Non-Small Cell Lung Cancer

Studies at this site

• Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer — Completed
• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed
• ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer — Completed